Abstract

BackgroundProstate cancer (PCa) is one of the most common cancers and the fifth leading cause of cancer-related death in men. Immune responses in the tumor microenvironment are hypothesized to be related to the prognosis of PCa patients; however, no studies are available to confirm the same. In this study, we aimed to explore the potential link between these two factors and identify new biomarkers to estimate the survival rate of PCa patients.MethodsA total of 490 cases were obtained from The Cancer Genome Atlas (TCGA) database. The gene expression data were analyzed by the ESTIMATE algorithm to evaluate the immune and stromal scores. The survival rate was calculated according to the case-specific clinical data. Enrichment analysis was performed to discover the main biological processes and signaling pathways of immune responses. We further identified and analyzed hub genes in the protein-protein interaction (PPI) network and evaluated their prognostic values.ResultsImmune score significantly correlated with immune cell infiltration and overall survival of PCa patients. The genes CXCR4 and GPR183, identified as hub genes in the PPI network, correlated with immune cell infiltration and prognosis of PCa patients.ConclusionCXCR4 and GPR183 participate in immune cell infiltration and function in PCa patients. The immune score, as well as the expression of CXCR4 and GPR183 in prostate cancer tissues, could be potential indexes for the prognosis of prostate cancer.

Highlights

  • Prostate cancer (PCa) is one of the most common cancers of men and the fifth leading cause of cancer-related morbidity in men worldwide [1]

  • Transcriptional expression files and clinical data of 490 prostate cancer patients were downloaded from the The Cancer Genome Atlas (TCGA) databank

  • The stromal score of PCa patients varied from -1,925.26 to 1771.63, and the immune score varied from -1,339.23 to 1,646.97

Read more

Summary

Introduction

Prostate cancer (PCa) is one of the most common cancers of men and the fifth leading cause of cancer-related morbidity in men worldwide [1]. For metastatic PCa patients, surgery or androgen deprivation is advised. The precise relationship between the prognosis of PCa and the immune responses is still unknown. Prostate cancer (PCa) is one of the most common cancers and the fifth leading cause of cancer-related death in men. Immune responses in the tumor microenvironment are hypothesized to be related to the prognosis of PCa patients; no studies are available to confirm the same. We aimed to explore the potential link between these two factors and identify new biomarkers to estimate the survival rate of PCa patients

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call